Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.12
+0.05 (0.22%)
At close: Jul 17, 2026, 4:00 PM EDT
23.11
-0.01 (-0.04%)
After-hours: Jul 17, 2026, 7:48 PM EDT
Nurix Therapeutics Employees
Nurix Therapeutics had 317 employees as of November 30, 2025. The number of employees increased by 31 or 10.84% compared to the previous year.
Employees
317
Change (1Y)
31
Growth (1Y)
10.84%
Revenue / Employee
$115,981
Profits / Employee
-$1,076,817
Market Cap
2.40B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Nov 30, 2025 | 317 | 31 | 10.84% |
| Nov 30, 2024 | 286 | 2 | 0.70% |
| Nov 30, 2023 | 284 | -13 | -4.38% |
| Nov 30, 2022 | 297 | 55 | 22.73% |
| Nov 30, 2021 | 242 | 107 | 79.26% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Biohaven | 274 |
| Immunome | 206 |
| Pharvaris | 134 |
| Mineralys Therapeutics | 76 |
| Nektar Therapeutics | 63 |
NRIX News
- 6 days ago - Nurix Therapeutics price target raised to $34 from $30 at Mizuho - TheFly
- 9 days ago - Nurix Therapeutics price target raised to $34 from $32 at Truist - TheFly
- 9 days ago - Nurix Therapeutics price target raised to $33 from $30 at RBC Capital - TheFly
- 9 days ago - Nurix Therapeutics price target raised to $40 from $34 at Stifel - TheFly
- 9 days ago - Nurix Therapeutics price target raised to $34 from $32 at H.C. Wainwright - TheFly
- 10 days ago - Nurix Therapeutics reports Q2 EPS (81c), consensus (72c) - TheFly
- 10 days ago - Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 days ago - Nurix Therapeutics Earnings release: Q2 2026 - Filings